TG Therapeutics

TGTX · NASDAQ · Healthcare

$49.76

+$0.21 (+0.42%) today

Loading live data...

Market Cap

$7.62B

24h Volume

$87.9M

P/E Ratio

18.2

52w High

$59.06

52w Low

$26.39

Est. AI Revenue

15%

Loading chart data...

Biotech using AI-driven clinical trial design and computational immunology for B-cell targeted therapies in autoimmune diseases and oncology.

CEO: Michael Weiss

Founded: 1993

HQ: New York, New York

Employees: 399

24 Hours+0.42%

7 Days-4.36%

30 Days-15.75%

1 Year+86.30%